A detailed history of Iht Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Iht Wealth Management, LLC holds 72,708 shares of ABBV stock, worth $13 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
72,708
Previous 57,424 26.62%
Holding current value
$13 Million
Previous $9.85 Million 45.78%
% of portfolio
0.42%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.5 Million - $3.05 Million
15,284 Added 26.62%
72,708 $14.4 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $118,414 - $138,281
-765 Reduced 1.31%
57,424 $9.85 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $204,889 - $233,452
1,282 Added 2.25%
58,189 $10.6 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $593,744 - $668,695
4,315 Added 8.2%
56,907 $8.82 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $284,413 - $329,249
2,129 Added 4.22%
52,592 $7.84 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $30,079 - $37,432
227 Added 0.45%
50,463 $6.8 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $35,863 - $41,301
248 Added 0.5%
50,236 $8.01 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $62,377 - $74,807
-451 Reduced 0.89%
49,988 $8.08 Million
Q3 2022

Nov 22, 2022

BUY
$134.21 - $153.93 $978,793 - $1.12 Million
7,293 Added 16.9%
50,439 $6.77 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $71,975 - $91,504
-523 Reduced 1.2%
43,146 $6.61 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $157,056 - $194,862
1,190 Added 2.8%
43,669 $7.08 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $54,896 - $69,460
511 Added 1.22%
42,479 $5.75 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $31 Million - $35.1 Million
-290,998 Reduced 87.4%
41,968 $4.53 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $282,699 - $314,943
-2,687 Reduced 0.8%
332,966 $37.5 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $3.79 Million - $4.17 Million
37,063 Added 12.41%
335,653 $36.3 Million
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $2.13 Million - $2.87 Million
-26,426 Reduced 8.13%
298,590 $32 Million
Q3 2020

Nov 19, 2020

BUY
$85.91 - $100.83 $24 Million - $28.1 Million
279,034 Added 606.83%
325,016 $28.5 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $19.6 Million - $26.2 Million
-267,341 Reduced 85.32%
45,982 $4.52 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $3.68 Million - $5.58 Million
57,066 Added 22.27%
313,323 $23.9 Million
Q4 2019

Feb 18, 2020

SELL
$72.13 - $90.25 $136,902 - $171,294
-1,898 Reduced 0.74%
256,257 $22.7 Million
Q3 2019

Nov 15, 2019

BUY
$62.98 - $75.72 $2.95 Million - $3.55 Million
46,849 Added 22.17%
258,155 $19.6 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $1.75 Million - $2.23 Million
26,613 Added 14.41%
211,306 $15.4 Million
Q1 2019

May 16, 2019

BUY
$77.14 - $90.79 $3.77 Million - $4.44 Million
48,867 Added 35.98%
184,693 $14.9 Million
Q4 2018

Feb 15, 2019

BUY
$77.85 - $96.01 $8.56 Million - $10.6 Million
109,949 Added 424.89%
135,826 $12.5 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $194,801 - $216,558
2,191 Added 9.25%
25,877 $2.45 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $275,445 - $325,913
3,068 Added 14.88%
23,686 $2.19 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $23,830 - $31,911
-259 Reduced 1.24%
20,618 $1.89 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $496,789 - $544,770
5,547 Added 36.18%
20,877 $2.08 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.07 Million - $1.37 Million
15,330
15,330 $1.39 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iht Wealth Management, LLC Portfolio

Follow Iht Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iht Wealth Management, LLC with notifications on news.